TCP pathologists are here to support you.
Thyroid Cytopathology Partners is partnered with Veracyte, the South San Francisco-based leader in molecular cytology, to provide cytopathology review for samples submitted for the Afirma® Thyroid FNA Analysis. We have assembled a highly-trained, sub-specialized group of cytopathologists who exclusively review thyroid nodule FNAs, ensuring exposure to both common and rare thyroid lesions.Download Thyroid Cytopathology Partners Bibliography
S. Thomas Traweek, MD
Dr. Traweek received his medical degree from the University of Texas Southwestern Medical School (Dallas). He then completed a residency in anatomic and clinical pathology and a fellowship in surgical pathology at Oregon Health Sciences University (Portland). Subsequently, he served as a research and clinical instructor for the Department of Pathology at Oregon Health Sciences University, as well as being a Hematopathology Research Fellow at The Portland Veterans Administration. Hospital. He also completed a fellowship in hematopathology with Dr. Henry Rappaport at City of Hope National Medical Center in Duarte, California. He subsequently was a staff pathologist at City of Hope and collaborated on projects with Dr. Hector Battifora to correlate gene expression with immunohistochemical results. Dr. Traweek then was Associate Professor of Pathology and Director of Hematopathology and Molecular Pathology at Duke University Medical Center. Dr. Traweek founded TCP in 2010.
Dr. Traweek is board certified in anatomic and clinical pathology, as well as in hematopathology. He is a member of several professional organizations including the American Society of Cytopathology, the College of American Pathologists, and the American Society of Clinical Pathologists. He is president and CEO of TCP.